Effects of sirolimus on lipids in renal allograft recipients: an analysis using the Framingham risk model (Q44064646)

29 November 2017

Effects of sirolimus on lipids in renal allograft recipients: an analysis using the Framingham risk model (English)

1 reference

29 November 2017

0 references

1 reference

Conrad B Blum

1

1 reference

PubMed ID

12118900

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

American Journal of Transplantation

29 November 2017

1 reference

29 November 2017

2

1 reference

29 November 2017

6

1 reference

29 November 2017

551-559

1 reference

Cardiovascular risk factors and diseases after renal transplantation

29 November 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

Hypertension in cyclosporin A-treated patients is independent of circulating endothelin levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

Cardiovascular disease risk profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

Hyperlipidaemia in renal transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

Effect of cyclosporin on plasma lipoproteins in bone marrow transplantation patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

Coronary risk in a British Punjabi population: comparative profile of non-biochemical factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

Risk factors for accelerated atherosclerosis in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

7 January 2021

Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

7 January 2021

Effects of steroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

7 January 2021

Cyclosporine-induced hypertension and decline in renal function in healthy volunteers

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

7 January 2021

Cyclosporine-induced hypertension after transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

7 January 2021

Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

7 January 2021

Hyperlipidemia in renal transplant recipients treated with sirolimus (rapamycin)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

7 January 2021

More on rifampin prophylaxis against Haemophilus influenzae b in day-care facilities

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

7 January 2021

Long-term cardiovascular morbidity and mortality in autosomal dominant polycystic kidney disease patients after renal transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

7 January 2021

The effects of steroid withdrawal on the lipoprotein profiles of cyclosporine-treated kidney and kidney-pancreas transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

7 January 2021

The influence of pretransplant lipoprotein abnormalities on the early results of renal transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

7 January 2021

The beneficial effects of steroid withdrawal on blood pressure and lipid profile in children posttransplantation in the cyclosporine era.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

7 January 2021

Oxidizability of low-density lipoproteins from Neoral and tacrolimus-treated renal transplant patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

7 January 2021

Serum total homocysteine concentration before and after renal transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

7 January 2021

Arabian Peninsula men tend to insulin resistance and cardiovascular risk seen in South Asians

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

7 January 2021

The seven countries study: 2,289 deaths in 15 years

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20610.X

7 January 2021

10.1034/J.1600-6143.2002.20610.X

Identifiers

DOI

1 reference

29 November 2017

1 reference

PubMed ID

12118900